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Chapter 12
An Ethical Code for Posthumous Medical 
Data Donation
Jenny Krutzinna, Mariarosaria Taddeo, and Luciano Floridi
Abstract This chapter follows the argument that personal medical data should be 
made available for scientific research by enabling and encouraging individuals to 
donate their medical records after death, provided that this can be done safely and 
ethically. While medical donation schemes with dedicated regulatory and ethical 
frameworks for blood, organ or tissue donations are already in place, no such ethical 
guidance currently exists with regard to personal medical data. In addressing this 
gap, this chapter presents the first ethical code for posthumous medical data dona-
tion (PMDD). It is based on five foundational principles and seeks to inform and 
guide the implementation of an effective and ethical PMDD scheme by addressing 
the key risks associated with the utilisation of personal health data for the promotion 
of the common good.
Keywords Data donation · Medical data ethics · Ethical code · Health records · 
Personal health data · Data philanthropy · Data ethics
12.1  Preamble
The importance and value of brain, body, organ and tissue donation after death has 
long been recognised, and relevant regulatory and ethical frameworks have been put 
in place to manage it. Medical data, which also hold enormous potential for medical 
research and for the improvement of health and social care on a large scale, has not 
as yet been incorporated into such frameworks. Neither is it currently possible to 
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donate one’s medical data posthumously.1 However, enabling such posthumous 
medical data donation (hereafter PMDD) is in the interest of individuals and society 
at large. It is important to make medical data available for scientific research by 
enabling and encouraging individuals to donate their medical records2 after death, 
similarly to how they can already donate bodies or body parts. This is why a research 
project on PMDD, developed by the Digital Ethics Lab at the Oxford Internet 
Institute has led to the formulation of this Ethical Code for Posthumous Medical 
Data Donation (hereafter the Code), which sets out the guiding ethical principles for 
such donations. An important limitation to note is that the Code focuses exclusively 
on ethical aspects. This means that important practical issues relating to law and 
governance will have to be addressed prior to and during its implementation.3
12.2  Considerations
• Recalling the Convention for the Protection of Human Rights and Fundamental 
Freedoms of the Council of Europe, Rome, 4.XI.1950;
• Recalling the Convention on Human Rights and Biomedicine and the additional 
protocols to the Convention of the Council of Europe, Oviedo, 4.IV.1997;
• Recalling the Universal Declaration of Human Rights, 10.XII.1948 and the 
Universal Declaration on the Human Genome and Human Rights, 11.XI.1997 
and the International Declaration on Human Genetic Data of the United Nations, 
16.X.2003;
• Recalling the Universal Declaration of Bioethical Principles of the United 
Nations 19.X.2005;
• Recalling the Declaration of Helsinki of the World Medical Association, 1.
VI.1964;
• Recalling the Regulation (EU) 2016/679 of the European Parliament and of the 
Council of 27 April 2016 on the protection of natural persons with regard to the 
processing of personal data and on the free movement of such data (GDPR), and 
repealing Directive 95/46/EC.
1 Arguably, there are no particular barriers to donate one’s data, at least in some jurisdictions such 
as the UK, where this could be done via an Advance Directive. However, the lack of coherent ethi-
cal and legal structure to facilitate such donation makes it practically impossible.
2 The term “medical records“is to be loosely understood, as the availability and format will vary 
between jurisdictions and it is unlikely that medical data are consolidated in one place.
3 See the concept of post-compliance soft ethics in Floridi, L. 2018. Soft ethics, the governance of 
the digital and the general data protection regulation. Philosophical Transactions of the Royal 
Society A 376 (2133): 20180081.





The sale, lease or commercial licensing of the data. It shall also include uses 
of the data to produce or manufacture products or services for general sale.
Donor The person-source of the data, or data subject.
Data Any donor-related data.
Database Repository (often online) built to facilitate access to data.
Directly identifying 
data





Any data that make possible the identification of the person concerned only 
through the use of a simple tool, such as a key.
Fully-anonymised 
data




Any data which is either predictive of genetic disease or can serve to identify 
the person as a carrier of a gene responsible for a disease or detect a genetic 
predisposition or susceptibility to a disease, whereas scientific proof for 
validity of that information is present.








The giving of one’s PMR for research purposes upon death.
PMDD activities Activities such as obtaining, handling, processing, storing and distributing of 
data, including all associated research activities.
PMDD institution 
(PMDDI)
The PMDDI is the institutional body acting as steward of all donated data.
Researcher Any person with a legitimate interest in conducting research, whether 
affiliated with an academic, commercial, public, private or other institution. 
It shall not include private individuals.
Steward Institution holding and maintaining the data. The steward assumes full 
responsibility for compliance with the legal and ethical rules that apply to 
collecting, processing and managing the data.
User Any person involved in collecting, storing, handling, processing, accessing, 
or managing the data.
12.4  Overview
The Code of Ethics on Posthumous Medical Data Donation (hereafter ‘the Code’) has 
been developed to establish the guiding ethical principles for Posthumous Medical Data 
Donation (hereafter ‘PMDD’), in recognition that PMDD constitutes an act that is both 
meaningful to an individual and valuable to the public and as such should be facilitated.
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12.4.1  Objectives
The key objective of the Code is to state the fundamental ethical principles which 
should govern all PMDD activities. In addition,
• any applicable national laws or local regulations are to be complied with at all 
times. The Code does not replicate, amend or overrule but complements any such 
instruments;4
• participation in PMDD activities is and remains voluntary; this includes every 
person’s right to accept or refuse participation at any point;
• the autonomy and confidentiality of all donors and their families shall be 
respected;
• special care will be taken in all PMDD activities to avoid discrimination against, 
or stigmatisation of, an individual, a family or a group;
• every care will be taken that the collected data is used, and in line with the pur-
poses for which it was donated, namely for ethically and scientifically sound 
research, and that it is not abandoned;
• the research process and the ethical guidelines will be reviewed by an indepen-
dent body on a regular basis to take into account any new developments in tech-
nology, law, and society. The results of such a review will be made public.
12.4.2  Scope
The Code shall apply to the full range of PMDD activities involving donated personal 
medical records (hereafter ‘PMR’). It shall not apply to other types of health- related 
data, nor shall it apply to donations made by living donors. For the purposes of the 
Code, PMDD shall not include donations made to private institutions for the purposes 
of commercial exploitation. The Code shall apply to donors, users, and researchers.
12.5  Foundational Ethical Principles
Five foundational principles aim to guarantee a minimum ethical standard to be 
maintained in all PMDD activities:
 1. Human dignity and respect for persons
 2. Promotion of the common good
 3. The right to Citizen Science
4 The Code presupposes some basic data protection and privacy safeguards in line with the legal 
instruments set out under “Considerations” above. This means that the Code may not be suffi-
ciently detailed in jurisdictions that do not subscribe to those international conventions, and further 
guidelines may be required.
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 4. Quality and good data governance
 5. Transparency, accountability, and integrity
12.5.1  Human Dignity and Respect for Persons
Human dignity and respect for persons shall be paramount in all PMDD activities. 
In particular,
• the dignity of the donor shall be protected at all times;
• the preferences and values of the donor shall be honoured at all times;
• the privacy of the donor shall be maintained;
• potential harm to the donor, any relatives and/or next of kin shall be minimised.
12.5.2  Promotion of the Common Good
The purpose of the PMDD database is to provide the means to generate and dissemi-
nate new medical knowledge to benefit the public. The donor’s wish to promote the 
common good by contributing to biomedical research shall be respected. This means:
• to maximise the morally good outcome, all PMDD shall be publicly accessible, 
and all research findings and results based on the data shall be published under 
an open licence;
• where the acceptance of a donation to the database carries a significant risk to 
relatives and/or family members, a careful balancing of harms and benefits 
should take place, which may lead to the rejection of the donation. Such rejec-
tions should be limited to serious cases of harm, to reduce the risk of excluding 
particularly valuable datasets, such as those relating to rare diseases and less 
common conditions. In all instances, the relatives and family members of the 
donor should be engaged in the process as much as is practically feasible to gain 
their support for the donation;
• prohibition of unethical research using PMDD without exception;
• prohibition of commercial exploitation of PMDD data where this could unfairly 
restrict access to treatments or cures;
• requesting proof of adequate benefit sharing measures prior to granting access to 
the PMDD database to a researcher.
12.5.3  The Right to Citizen Science
Citizens’ right to participate in the scientific process in its entirety should be recog-
nised and respected at all times. In particular,
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• all donations should be accepted, unless there are solid grounds for rejecting a 
particular donation, such as a disproportionate risk of harm to others;
• the optimal use of donated data shall be guaranteed, and data shall not be 
abandoned;
• all results and findings shall be shared with the public in an accessible and timely 
manner;
• the public shall be actively involved in the further development of PMDD and 
encouraged to participate in deliberations about the wider social impact of 
PMDD.
12.5.4  Quality and Good Data Governance
Quality management and data governance shall be taken seriously when accepting, 
handling or using PMDD data. In particular,
• users and other PMDDI staff shall be adequately trained for their respective roles 
within the PMDD activities, including knowledge and understanding of this 
Code and any applicable data protection and privacy laws and regulations (such 
as the EU’s General Data Protection Regulation);
• safe and secure storage facilities shall be used for the data, including use of 
adequate and updated encryption techniques, to minimise the risk of unauthor-
ised access, data loss, or misuse. Proper record-keeping and access management 
shall be maintained to ensure full traceability of the location of, and access to, 
any PMDD;
• PMDDs shall be de-identified using currently available standards, and re- 
identification shall be prohibited. Quality control mechanisms for PMRs shall be 
applied prior to data being added to the database;
• mechanisms should be adopted for ensuring the sustainability of the database for 
future use, including procedures to be followed in case of discontinuance of the 
PMDDI.
12.5.5  Transparency, Trust, and Integrity
Transparency, trust, and integrity shall inform all PMDD activities, including com-
munications with the donor and the public. In particular,
• communications with donors, any relatives or next of kin, and the public shall be 
open, honest, clear, and objective. Any information provided shall be compre-
hensible to a non-expert person and shall be accessible;
• clear and transparent procedures for deciding requests for data access shall be 
established and made public, and shall apply equally to all researchers regardless 
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of their affiliation. All access requests, whether granted or declined, shall be 
made public;
• mechanisms to ensure accountability and to handle complaints shall be imple-
mented, including mechanisms for identifying, reporting and managing incidents 
such as breaches, losses of data, or unauthorised access. Any incident shall be 
followed by rigorous investigation, and corresponding sanctions shall be insti-
tuted. In addition, procedures for handling lawful requests from law enforcement 
agencies shall be established;
• full disclosure of any financial arrangements involving PMDD data or financial 
gains derived from PMDD activities will be made.
12.6  Obtaining PMRs for Research Purposes
PMR shall be obtained and used for research purposes in accordance with applica-
ble national laws and local regulations, and the principles set forth in the Code.
Due to the anticipated benefit to be derived from the research to be conducted 
using the data, resources shall be dedicated to encourage participation in PMDD. In 
particular, information shall be provided to the public to encourage donations, while 
at the same time safeguarding the voluntariness of participation.
Consent shall be required for all collections of PMDD and for the use of PMDD 
for biomedical research purposes, even where local laws do not require such authori-
sation. As part of the consent procedure, participation will be explained as an oppor-
tunity to contribute in the long term to the improvement of other people’s health. 
Broad consent to research falling within the guidelines of this Code shall be deemed 
sufficient, as it is not possible to anticipate all ethically and scientifically sound 
future research uses.
12.6.1  Obtaining Consent
Prior to giving informed consent, the person concerned shall be offered appropriate 
information about the nature and purpose of PMDD, including examples of the type 
of research for which it will be used, the financial interests of the data collecting 
entity, and the management of access to and use of the data, including the kinds of 
safeguards that will be maintained.
Donors shall be informed that the full PMRs will be transferred to the PMDDI, 
including identifying information, to enable linkage between different datasets 
which is necessary to ensure maximum scientific utility of the overall database. 
However, donors shall be free to place restrictions on the use of their data and to 
exclude subsets of data from their donations. These preferences shall be recorded in 
the PMR in full. Donors shall be informed of their right to make changes to their 
preferences or to withdraw consent at any point prior to their death.
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Donors shall be encouraged to discuss their decision with their relatives, espe-
cially those with close genetic links.
Donors shall be informed that the use of their PMDD is not guaranteed and that 
in some rare instances a particular PMDD may be rejected if it poses a significant 
risk of harm to an individual or a group. Information shall be provided on possible 
reasons for exclusion.
Consent shall be appropriately documented in the PMR and at the PMDDI.
12.6.2  Persons Unable to Give Consent
To avoid the exclusion of vulnerable populations from benefiting from the scientific 
advances resulting from large-scale biomedical research, and to ensure their repre-
sentation within the data underlying such research, an active effort shall be made to 
include PMRs from all groups.
Where an individual is permanently unable to provide consent, due to a lack of 
legal capacity, the registration of a donor and subsequent donation may be carried 
out with the authorisation of the person’s legal representative or guardian. The indi-
vidual concerned shall be involved in the decision-making process as far as 
possible.
Similarly, where a minor is concerned, the parents or legal guardian shall be 
permitted to authorise a donation. The opinion of the minor shall be taken into con-
sideration in proportion to the age and degree of maturity of the child.
Where an individual is temporarily unable to provide consent, due to a lack of 
legal capacity, registration as a donor shall be held off until capacity to consent is 
regained or a permanent incapacity has been confirmed by the medical 
professional.
12.6.3  Changing or Withdrawing Consent
Donors can withdraw consent for participation in PMDD at any time by submitting 
a revised authorisation form, or by notifying a health care professional. The objec-
tion will be recorded in the PMR and will ensure that data is not submitted to the 
PMDD database on the donor’s death.
It shall also be possible for a person to record an objection to PMDD in their 
PMR.
A decision to object to PMDD, or to change or withdraw consent once given, 
shall not have a negative impact on the medical treatment or care of the person or 
lead to discrimination against that person.
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Where a legal representative or guardian gave the authorisation for PMDD, the 
right to change or withdraw consent remains with that person for as long as they 
shall have legal guardianship of that person.
12.6.4  Refusing Donations
There may be ethical reasons for excluding a particular PMDD donation, which 
may be grounded, inter alia, in the nature or the source of data. The following list is 
not exhaustive, and there may be other grounds on which a PMDDI may decide to 
refuse to accept a PMDD.
The right of a PMDDI to refuse a PMDD shall be maintained, as the overall cost 
of these refusals would be minimal, since the value lies in well-curated, large data-
sets, rather than individual datasets.
12.6.4.1  Refusing a PMDD on Grounds of the Data’s Nature
Where the donor’s data may reveal sensitive data about related people, a stewarding 
PMDDI may decide to refuse a PMDD. In particular, where genomic data reveal 
information about family members, it may be preferable to exclude such data from 
the donation where a comprehensive risk assessment reveals an unacceptably high 
risk to living people. This may apply especially where the relatives are vulnerable 
people and/or the condition is a hereditary disease, which may lead to stigma and/
or discrimination.
12.6.4.2  Refusing a PMDD on Grounds of the Data Source
In some rare cases, there may be reasons to reject a PMDD on the basis of its source. 
This means disallowing a particular individual from participating in PMDD, where 
a donation would carry a disproportionate risk to others. An example could be close 
relatives of acting politicians or diplomats, where there is a national interest in 
avoiding the exposure of vulnerabilities to outside influences.
12.6.4.3  Other Grounds for Refusing a PMDD
An institution may refuse to accept a particular PMDD on other grounds, including, 
for example, the potentially illegal nature of the collected data, but any reasons 
should be made sufficiently clear to the potential donor.
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12.7  Research Approval, Conduct and Oversight
In accordance with the foundational principles of the Code, it will be fundamental 
for the success of the PMDD activities that public trust is maintained. For this, it is 
crucial to manage research activities carefully, by maintaining transparency and 
ensuring accountability of any individual involved.
12.7.1  General Principles
12.7.1.1  Prohibition of Financial Gain5
It shall be prohibited to gain financially from PMDD. Therefore, donors will not be 
offered any financial or other inducement to participate in PMDD. Since participation 
does not entail any expense for the donor, the issue of reimbursement does not arise.
The PMDDI shall not be permitted to sell data obtained from PMDD activities, 
or to make a profit from such activities. Any profits resulting from the charging of 
access or licencing fees have to reinvested in the maintenance and improvement of 
the PMDD database. The sole purpose of any fee shall be to support the financing 
of costs, maintenance and improvement of the PMDD database, and shall not be 
used to make profits.
12.7.1.2  Confidentiality6
All data in relation to donors and their families shall be collected, processed and 
used in accordance with the principle of confidentiality and the right to respect for 
private life.
The steward will ensure that data are anonymised, linked, and stored to the high-
est standards of security. Researchers will only be given access to anonymised data.
All users and staff handling the data will receive appropriate training for main-
taining confidentiality and adherence with all relevant legislation.
Systems for data security and storage will be kept up to date and will be of the 
highest technical standard.
5 It is important to note that the research in this article has focused exclusively on the ethical issues 
of PMDD, which means that governance questions have not been answered. This includes the ques-
tion of the legal nature of the institutional body (the PMDDI), which will need to be addressed 
prior the implementation of a PMDD scheme.
6 These technical issues will need to be addressed more fully prior to the implementation of a PMDD 
scheme. Maintaining confidentiality through anonymization will have to  be  reconciled 
with the need to retain an option for re-identification for quality management purposes. The Code 
follows current practices in other types of medical donation schemes, e.g. biobanking, where ano-
nymized data is made available to researchers and identifying data is kept separate and is not made 
available for research.
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12.7.1.3  Data Custody
Custody of the data will be transferred to the PMDDI upon the donor’s death. This 
conveys a range of rights to the stewarding institution, in particular the right to take 
legal action against unauthorised use or abuse of the data. Donors will not have 
property rights in the data.
The PMDDI will not exercise their right to sell the data to third parties but will 
act as steward of the database, maintaining and developing it for the common good 
in accordance with its purpose.
This does not affect the right of the donor to give away, sell, or donate data to 
other parties.
12.7.1.4  Data Protection
All data will be collected, stored and handled in accordance with applicable data 
protection laws and regulations to safeguard the integrity of all data, e.g. in compli-
ance with the EU’s General Data Protection Regulation.
12.7.1.5  Directly Identifiable Data
Directly identifiable data, which will necessarily be included in the transfer of the 
PMR to the PMDDI, will be separated from the medical data of the donor prior to 
being added to the database. An arbitrary code without any external meaning (that 
is, for example, not a National Insurance number or similar) will be attached to link 
the personal identifying information to the medical information. This option for re- 
identification is necessary for data quality management: to eliminate redundant 
data, verify data accuracy and completeness, to establish correct linkages among 
databases, and to identify data which may need to be withdrawn.
Identifying information will be held in a separate data vault with restricted 
access, controlled by a senior steward at the PMDDI. The access key to the code for 
re-linking identifying information to the data will never be shared with external 
agents, such as researchers, and will only be accessible to a select few PMDDI staff 
who are ethically trained and sign special confidentiality agreements.
12.7.1.6  Information on Health and Hereditary Disease
The PMDDI will not share data or health information with living relatives or other 
interested parties under any circumstances. This includes information on potential 
hereditary disease.
It is, however, possible for the donor to nominate specific individuals who are to 
receive a copy of the PMR upon the donor’s death. It is the responsibility of the 
donor to ensure that the contact details of the recipients are kept up to date.
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12.7.2  Research Access
The PMDDI will retain full control of all access to, and uses of, the data in the data-
base. No exclusive access will be granted to any party.
To build and maintain a relationship of public trust, the PMDDI will inform the 
public of the rules for access, any requests made, access granted or refused, and any 
research results.
Access to the database by law enforcement agencies will be granted only under 
court order, and will be resisted in all other circumstances. Any such requests will 
be reported to the public in so far as this is legally permissible (see also clause 
12.7.2.1).
The PMDDI may charge a reasonable fee for access to the data for approved 
research purposes. This fee may vary depending on the expected financial benefit 
from use of the data. However, the fee should not be so excessive as to prevent 
legitimate research from being conducted due to purely economic reasons, and it 
may in some circumstances be advisable to waive the fee entirely. Any profit occur-
ring as a result of the fee system is regulated by clause 12.7.1.1.
12.7.2.1  Access Requests
The PMDDI will have overall decision-making authority over any access requests 
to the database. A special advisory board may be set up and charged with this task. 
However, routine applications may be delegated to appropriate working groups to 
provide more efficient services to the research community and to the public.
The PMDDI will provide public explanations of all policies and procedures for 
research access. These documents will continue to be developed to reflect relevant 
technical, legal and social changes, but will never abandon the principles of fairness 
and transparency in decision-making.
Access to the data will be granted only for scientifically and ethically approved 
research. Requestors will have to demonstrate benefit-sharing mechanisms and will 
have to have obtained research ethics approval from an appropriate body prior to 
being granted access to the data.
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12.7.2.2  Research Results
All researchers accessing the database will be required to provide the results from 
their analyses made using the data, and any relevant supporting information, to the 
PMDDI to make them subsequently available to all other legitimate researchers 
with approved access to the database.
It is a requirement on all researchers seeking access to place the findings, whether 
positive or negative, from all research based on the PMDD data in the public domain. 
Publication of results shall be in peer-reviewed scientific literature wherever this is 
possible, open access by preference, or on the website of the PMDDI.
12.7.3  Research Oversight
Any PMDD activities will be conducted in accordance with national research gov-
ernance frameworks and national research guidelines.
Independent periodic reviews of the quantity and quality of access requests, the 
research conducted, and the published results will be conducted and the findings 
will be made public.
As the purpose of PMDD is to generate new knowledge to promote population 
health, particular focus shall be placed on the dissemination of research outcomes. 
Where the independent reviewers are not satisfied that the principles of the Code are 
sufficiently upheld by the researchers, the PMDDI shall be required to review its 
access procedures to ensure that only those research requests are granted that prom-
ise to honour the principles of the Code.
12.7.4  Contingency Planning
The PMDDI shall develop a detailed contingency strategy for handling the PMDDI 
data and database in case of liquidation or termination of the PMDDI. The goal of 
the strategy must be to ensure the continuous protection of the rights of the donors 
and their families, and to respect their wishes that their data be used for research 
purposes. As such, the strategy should provide detailed plans for transferring the 
data to another steward so that research may continue on the data.
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Annex: Sample PMDD Authorisation Form
To be completed by donor and signed by a witness.








I WISH TO DONATE MY MEDICAL DATA AFTER MY DEATH.
I UNDERSTAND THAT THEY MAY BE USED FOR RESEARCH 
PURPOSES.
Please read the “Notes on completing these forms” then tick as 
appropriate
 1. Data retention
⎕ I consent to my medical data being retained indefinitely.
OR
⎕ My medical data can be retained for a maximum of ___ years.
 2. Data types
⎕ I consent to all my medical data being used.
OR
⎕ I wish to exclude the following data from my donation:
_____________________________________________
 3. Research purposes
⎕ I consent to my medical data being used for all research that has received 
ethics approval by an official REC within the European Economic Area 
(EU, plus Iceland, Liechtenstein and Norway).
 4. Copy of record
⎕ I wish the following named individuals to receive a complete copy of my 








Date, Signature of donor
Date, Signature of witness
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